APA (7th ed.) Citation

G, B. B., BJ, B., C, B., JM, D., AT, P., PJ, N., . . . AT, K. (2026). Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(1), 96. https://doi.org/10.2967/jnumed.125.270481

Chicago Style (17th ed.) Citation

G, Belge Bilgin, et al. "Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 1 (2026): 96. https://doi.org/10.2967/jnumed.125.270481.

MLA (9th ed.) Citation

G, Belge Bilgin, et al. "Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 1, 2026, p. 96, https://doi.org/10.2967/jnumed.125.270481.